Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules

World Journal of Surgery

Volumn 34, Issue 11, 2010, Pages 2595-2603

  Musholt, Thomas J ^a   Fottner, Christian ^a   Weber, Matthias M ^a   Eichhorn, Waltraud ^a   Pohlenz, Joachim ^a   Musholt, Petra B ^a   Springer, Erik ^a   Schad, Arno ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; PROTEIN RET; RET PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; GENETICS; HUMAN; MUTATION; NEEDLE BIOPSY; PATHOLOGY; THYROID NODULE; THYROID TUMOR;

ADENOCARCINOMA, PAPILLARY; BIOPSY, FINE-NEEDLE; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS; THYROID NODULE;

EID: 79952639915     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0729-4     Document Type: Article

References (35)

1. Tee YY, Lowe AJ, Brand CA et al (2007) Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg 246:714-720
2. Hassan I, Osei-Agymang T, Fernandez ED et al (2008) Does fineneedle aspiration cytology optimize the surgical management of thyroid disorders in endemic goiter region Endocr Pathol 19:34-39
3. Lundgren CI, Zedenius J, Skoog L (2008) Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 32:1247-1252
4. Lewis CM, Chang KP, Pitman M et al (2009) Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid 19:717-723
5. Nikiforov YE (2008) Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21(Suppl 2):S37-S43
6. Musholt PB, Musholt TJ, Morgenstern SC et al (2008) Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J Surg 32:722-728
7. Imkamp F, von Wasielewski R, Musholt TJ et al (2007) Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts. J Surg Res 143:350-363
8. Santoro M, Melillo RM, Carlomagno F et al (2004) Minireview: RET: normal and abnormal functions. Endocrinology 145: 5448-5451
9. Sapio MR, Posca D, Troncone G et al (2006) Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 154:341-348
10. Sapio MR, Posca D, Raggioli A et al (2007) Detection of RET/ PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol 66:678-683
11. Scheumann GF, Seeliger H, Musholt TJ et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677-684
12. Peng Y, Wang HH (2008) A meta-analysis of comparing fineneedle aspiration and frozen section for evaluating thyroid nodules. Diagn Cytopathol 36:916-920
13. Musholt PB, Imkamp F, von Wasielewski R et al (2003) RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hurthle cell carcinomas Surgery 134:881-889; discussion 889
14. Musholt TJ, Musholt PB, Khaladj N et al (2000) Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 128:984-993
15. Cameselle-Teijeiro J, Abdulkader I, Perez-Becerra R et al (2009) BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion Hum Pathol 40:1029-1035
16. Chung KW, Yang SK, Lee GK et al (2006) Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol 65: 660-666
17. Xing M, Tufano RP, Tufaro AP et al (2004) Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89:2867-2872
18. Cohen Y, Rosenbaum E, Clark DP et al (2004) Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 10:2761-2765
19. Jin L, Sebo TJ, Nakamura N et al (2006) BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 15:136-143
20. Kuru B, Gulcelik NE, Gulcelik MA et al (2010) The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules. Langenbecks Arch Surg 395:127-132
21. Domingues R, Mendonca E, Sobrinho L et al (2005) Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology 16: 27-31
22. Fugazzola L, Puxeddu E, Avenia N et al (2006) Correlation between BRAF V600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer 13:455-464
23. Ito Y, Yoshida H, Maruo R et al (2009) BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease- free survival of patients. Endocr J 56:89-97
24. Lee JH, Lee ES, Kim YS (2007) Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer 110:38-46
25. Tang KT, Lee CH (2010) BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications. J Chin Med Assoc 73:113-128
26. Lupi C, Giannini R, Ugolini C et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085-4090
27. Oler G, Cerutti JM (2009) High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115:972-980
28. Kim SK, Song KH, Lim SD et al (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137-141
29. Guan H, Ji M, Bao R et al (2009) Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 94:1612-1617
30. Nikiforova MN, Tseng GC, Steward D et al (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600-1608
31. Sapio MB, Guerra A, Posca D et al (2007) Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocrine-Related Cancer 14:1089-1097
32. Yip L, Nikiforova MN, Carty SE et al (2009) Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 146:1215-1223
33. Xing M, Clark D, Guan H et al (2009) BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982
34. Lee X, Gao M, Ji Y et al (2009) Analysis of differential BRAF(V600E) mutational status in highly aggressive papillary thyroid microcarcinoma. Ann Surg Oncol 16:240-245
35. Elisei R, Ugolini C, Viola D et al (2008) BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93:3943-3949